증상을 동반한 전립선비대증에 대한 일차적 치료로서 Prazosin의 효과
The Effect of Prazosin as a First-Line Therapy for the Symptomatic Benign Prostatic Hypertrophy
이종진, 최용섭,
소속 상세정보
이종진 ( )
연세대학교
최용섭 ( )
연세대학교
KMID : 0358319930340040855
Abstract
We evaluated 41 patients with symptomatic benign prostatic hypertrophy who were treated with prazosin alone more than 3 months. Among them, 21 patients(51.2%) showed improvement of both symptom score and maximal flow rate. There was the similar
effectiveness on the patients with acute urinary retention as on the patients without retention. The pretreated prostate volume and prostate specific antigen were not statistically different between the responders and non-responders. after with
drawl of
the medication, almost all patients immediately complained of the symptoms worsened again. So, we concluded that the α-blocker can be used as a first-line therapy in selected patients with symptomatic benign prostatic hypertrophy with temporal
effect.
키워드
원문 및 링크아웃 정보
등재저널 정보